1. Home
  2. VATE vs CTSO Comparison

VATE vs CTSO Comparison

Compare VATE & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VATE
  • CTSO
  • Stock Information
  • Founded
  • VATE 1994
  • CTSO 1997
  • Country
  • VATE United States
  • CTSO United States
  • Employees
  • VATE N/A
  • CTSO N/A
  • Industry
  • VATE Metal Fabrications
  • CTSO Medical/Dental Instruments
  • Sector
  • VATE Industrials
  • CTSO Health Care
  • Exchange
  • VATE Nasdaq
  • CTSO Nasdaq
  • Market Cap
  • VATE 65.1M
  • CTSO 72.8M
  • IPO Year
  • VATE 1996
  • CTSO N/A
  • Fundamental
  • Price
  • VATE $5.69
  • CTSO $0.96
  • Analyst Decision
  • VATE
  • CTSO Buy
  • Analyst Count
  • VATE 0
  • CTSO 2
  • Target Price
  • VATE N/A
  • CTSO $5.50
  • AVG Volume (30 Days)
  • VATE 22.6K
  • CTSO 139.7K
  • Earning Date
  • VATE 11-05-2025
  • CTSO 11-06-2025
  • Dividend Yield
  • VATE N/A
  • CTSO N/A
  • EPS Growth
  • VATE N/A
  • CTSO N/A
  • EPS
  • VATE N/A
  • CTSO N/A
  • Revenue
  • VATE $995,000,000.00
  • CTSO $36,107,520.00
  • Revenue This Year
  • VATE N/A
  • CTSO $11.93
  • Revenue Next Year
  • VATE N/A
  • CTSO $21.22
  • P/E Ratio
  • VATE N/A
  • CTSO N/A
  • Revenue Growth
  • VATE N/A
  • CTSO 20.18
  • 52 Week Low
  • VATE $3.25
  • CTSO $0.71
  • 52 Week High
  • VATE $13.79
  • CTSO $1.61
  • Technical
  • Relative Strength Index (RSI)
  • VATE 58.49
  • CTSO 48.40
  • Support Level
  • VATE $4.98
  • CTSO $0.85
  • Resistance Level
  • VATE $5.72
  • CTSO $0.99
  • Average True Range (ATR)
  • VATE 0.39
  • CTSO 0.07
  • MACD
  • VATE 0.11
  • CTSO 0.00
  • Stochastic Oscillator
  • VATE 97.27
  • CTSO 37.67

About VATE INNOVATE Corp.

Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting station across the United States.

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

Share on Social Networks: